Target intelligence / Profile preview

Epidermal keratinocyte differentiation and skin barrier pathways

Molecular classification
Other
01

Overview

Epidermal keratinocyte differentiation and skin barrier pathways represent the coordinated biological processes responsible for maintaining the skin's integrity and protective function (PMID: 30125317). This program involves the maturation of keratinocytes from the basal layer into corneocytes, characterized by the sequential expression of structural proteins such as filaggrin, loricrin, and involucrin, which form the cornified envelope (PMID: 21833085). Concurrently, the synthesis and secretion of specialized lipids, including ceramides and fatty acids, create the extracellular lamellar matrix essential for preventing transepidermal water loss (StatPearls: Physiology, Skin Barrier). Dysregulation of these pathways is central to the pathogenesis of inflammatory skin diseases like atopic dermatitis and psoriasis, where barrier defects allow for allergen penetration and chronic inflammation (PMID: 25352319). Therapeutic agents like Tapinarof and Vitamin D analogs target these pathways by modulating transcription factors, such as the Aryl hydrocarbon receptor (AhR), that promote the expression of barrier proteins (PMID: 33531143). Understanding these pathways is crucial for developing treatments that go beyond symptom management to restore the skin's fundamental physiological barrier.

Other names
Keratinocyte differentiation programEpidermal differentiation complex (EDC) pathwaysSkin barrier functionEpidermal permeability barrier pathways
02

Mechanism of action

Modulation of transcription factors (e.g., AhR, VDR, RAR) and inhibition of barrier-disrupting cytokines (e.g., IL-4, IL-13) to restore structural protein and lipid synthesis.

03

Biological functions

Cell differentiationBarrier formationLipid metabolismCell-cell adhesionInnate immunity
04

Disease associations

Atopic dermatitisPsoriasisIchthyosisSkin cancerXerosis
05

Safety considerations

Local skin irritationErythemaPhotosensitivityPotential for systemic absorption in barrier-compromised patients
06

Interacting drugs

Tapinarof

5 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Filaggrin (FLG) expressionLoricrin (LOR) expressionInvolucrin (IVL) expressionKeratin 1/10 levels

Beyond the preview

Go deeper on Epidermal keratinocyte differentiation and skin barrier pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal keratinocyte differentiation and skin barrier pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call